Bigelow Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,005
Closed -$308K 155
2023
Q4
$308K Sell
6,005
-653
-10% -$34.3K 0.17% 124
2023
Q3
$386K Hold
6,658
0.22% 108
2023
Q2
$426K Sell
6,658
-80
-1% -$5.36K 0.23% 105
2023
Q1
$467K Sell
6,738
-968
-13% -$68.3K 0.27% 100
2022
Q4
$554K Sell
7,706
-775
-9% -$58.4K 0.32% 92
2022
Q3
$603K Buy
8,481
+394
+5% +$28.6K 0.36% 79
2022
Q2
$623K Buy
8,087
+561
+7% +$42.7K 0.34% 82
2022
Q1
$550K Buy
7,526
+280
+4% +$18.8K 0.26% 94
2021
Q4
$452K Buy
7,246
+750
+12% +$44K 0.21% 101
2021
Q3
$384K Sell
6,496
-2,082
-24% -$137K 0.19% 107
2021
Q2
$573K Buy
8,578
+332
+4% +$21.6K 0.28% 92
2021
Q1
$521K Buy
8,246
+82
+1% +$5.1K 0.26% 92
2020
Q4
$506K Buy
8,164
+667
+9% +$41K 0.27% 91
2020
Q3
$452K Buy
7,497
+30
+0.4% +$1.81K 0.27% 94
2020
Q2
$439K Buy
7,467
+2,708
+57% +$162K 0.28% 89
2020
Q1
$265K Sell
4,759
-310
-6% -$18.9K 0.2% 121
2019
Q4
$325K Buy
+5,069
New +$290K 0.19% 124
2018
Q4
Sell
-3,800
Closed -$236K 147
2018
Q3
$236K Sell
3,800
-718
-16% -$42.6K 0.16% 137
2018
Q2
$250K Hold
4,518
0.17% 133
2018
Q1
$286K Buy
+4,518
New +$291K 0.19% 128

Other funds holding BMY

Bigelow Investment Advisors's BMY Position: Q1 2024 in Review

Bigelow Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 6,005 shares — an estimated $308K sold.

Bigelow Investment Advisors first reported a position in BMY in Q1 2018 and held it in 20 quarters. The position peaked at $623K in Q2 2022. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Bigelow Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • Bigelow Investment Advisors sold 6,005 Bristol-Myers Squibb shares in Q1 2024, an estimated $308K.
  • Bigelow Investment Advisors first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 20 quarters.
  • Bigelow Investment Advisors's Bristol-Myers Squibb position peaked at $623K in Q2 2022.
  • 2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Bigelow Investment Advisors's 13F filing for Q1 2024, filed 8 May 2024.